Founder And Ceo
CurrentFounder & CEO, NutreGenic USA Life SciencesHello, everyone! I'm Richard Hart. With a robust 30-year track record of launching and scaling innovative companies, I am currently steering NutreGenic USA Life Sciences through an exciting phase in the expansive $157.9 billion dental healthcare market. Our mission is to revolutionize care for the 202,000 dentists across the USA and further extend our reach to the 1.6 million dental professionals globally.At NutreGenic, we specialize in pioneering dental solutions through our line of four patented human growth factor (HGF) based products. Designed to drastically improve recovery times and enhance overall dental and systemic health, our offerings include:B2B Products:xOralFix and xOralGel: Tailored to boost recovery post-dental procedures, enhancing patient satisfaction and care.B2C Products:xOralHealth and xOralGum: Available through dental professionals, these products aim to improve outcomes for both invasive and mildly invasive procedures, contributing to better systemic health.Value Proposition of xOral Products:Enhanced Patient Outcomes: Our innovative HGF formula has been proven to improve recovery rates by up to 80% across various dental procedures.Increased Dentist Bottomline: Dentists using our products have seen income increases of up to 40% without the need for additional patients, staff, or equipment. Our solutions also reduce the dependency on post-procedure pain management and antibiotics.Our impact is exemplified by our co-founder, Dr. Xerxez Calilung DDS, whose practice has seen a revenue boost of $2.4 million since 2018, thanks to the integration of NutreGenic products.We are actively seeking to connect with investors interested in joining us during our $2 million seed funding round. For more details, please visit NutreGenic.com or contact us directly at Invest@NutreGenic.com to schedule a Zoom-n-Learn session or to access our Investor's Pitch Deck.Thank you for your interest